Comparison of dual drug-eluting Cilotax stent and paclitaxel-eluting Taxus Liberte stent in native coronary artery lesions

American Journal of Cardiology

Volumn 107, Issue 7, 2011, Pages 990-994

  Lee, Cheol Whan ^a   Park, Duk Woo ^a   Seung, Ki Bae ^b   Kim, Pum Joon ^b   Park, Hun Joon ^b   Kim, Won Jang ^a   Lee, Jong Young ^a   Kang, Soo Jin ^a   Lee, Seung Hwan ^a   Kim, Young Hak ^a   Park, Seong Wook ^a   Park, Seung Jung ^b  

^a University of Ulsan   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CILOSTAZOL; PACLITAXEL;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IN-STENT LATE LOSS; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SAFETY; STENT THROMBOSIS;

ADULT; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; KOREA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; TETRAZOLES;

EID: 79952771681     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.11.021     Document Type: Article

References (17)

1. P.W. Serruys, M.J.B. Kutryk, and A.T.L. Ong Coronary-artery stents N Engl J Med 354 2006 483 495 (Pubitemid 43200299)
2. J. Daemen, P. Wenaweser, K. Tsuchida Tsuchida, L. Abrecht, S. Vaina, C. Morger, N. Kukreja, P. Jni, G. Sianos, G. Hellige, R.T. van Domburg, O.M. Hess, E. Boersma, B. Meier, S. Windecker, and P.W. Serruys Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678 (Pubitemid 46281313)
3. G. Montalescot, J.S. Hulot, and J.P. Collet Stent thrombosis: who's guilty? Eur Heart J 30 2009 2685 2688
4. T. Kunishima, H. Musha, F. Eto, T. Iwasaki, J. Nagashima, Y. Masui, T. So, T. Nakamura, N. Oohama, and M. Murayama A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation Clin Ther 19 1997 1058 1066 (Pubitemid 27508940)
5. D.J. Angiolillo, P. Capranzano, S. Goto, M. Aslam, B. Desai, R.K. Charlton, Y. Suzuki, L.C. Box, S.B. Shoemaker, M.M. Zenni, L.A. Guzman, and T.A. Bass A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study Eur Heart J 29 2008 2202 2211
6. S.W. Park, C.W. Lee, H.S. Kim, H.J. Lee, H.K. Park, M.K. Hong, J.J. Kim, and S.J. Park Comparison of cilostazol versus ticlopidine therapy after stent implantation Am J Cardiol 84 1999 511 514 (Pubitemid 29408579)
7. S.W. Lee, S.W. Park, M.K. Hong, C.W. Lee, Y.H. Kim, J.H. Park, S.J. Kang, K.H. Han, J.J. Kim, and S.J. Park Comparison of cilostazol and clopidogrel after successful coronary stenting Am J Cardiol 95 2005 859 862 (Pubitemid 40386798)
8. S.W. Lee, S.W. Park, M.K. Hong, Y.H. Kim, B.K. Lee, J.M. Song, K.H. Han, C.W. Lee, D.H. Kang, J.K. Song, J.J. Kim, and S.J. Park Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis J Am Coll Cardiol 46 2005 1833 1837 (Pubitemid 41579804)
9. T. Tanaka, T. Ishikawa, M. Hagiwara, K. Onoda, H. Itoh, and H. Hidaka Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor, on the contraction of vascular smooth muscle Pharmacologist 36 1988 313 320
10. J.S. Douglas Jr, D.R. Holmes Jr., D.J. Kereiakes, C.L. Grines, E. Block, Z.M. Ghazzal, D.C. Morris, H. Liberman, K. Parker, C. Jurkovitz, N. Murrah, J. Foster, P. Hyde, G.B. Mancini, W.S. Weintraub Cilostazol for Restenosis Trial (CREST) Investigators Coronary stent restenosis in patients treated with cilostazol Circulation 112 2005 2826 2832 (Pubitemid 41641677)
11. T. Inoue, T. Uchida, M. Sakuma, Y. Imoto, Y. Ozeki, Y. Ozaki, Y. Hikichi, and K. Node Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantation J Am Coll Cardiol 44 2004 1408 1414 (Pubitemid 39303941)
12. S.W. Lee, S.W. Park, Y.H. Kim, S.C. Yun, D.W. Park, C.W. Lee, M.K. Hong, H.S. Kim, J.K. Ko, J.H. Park, J.H. Lee, S.W. Choi, I.W. Seong, Y.H. Cho, N.H. Lee, J.H. Kim, K.J. Chun, and S.J. Park Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients) J Am Coll Cardiol 51 2008 1181 1187 (Pubitemid 351382092)
13. U. Tamhane, P. Meier, S. Chetcuti, K.Y. Chen, S.W. Rha, M.P. Grossman, and H. Gurm Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent based PCI: a meta-analysis of randomised controlled trials Eurointervention 5 2009 384 393
14. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, G.A. van Es, P.G. Steg, M.A. Morel, L. Mauri, P. Vranckx, E. McFadden, A. Lansky, M. Hamon, M.W. Krucoff, P.W. Serruys Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
15. R.A. Byrne, A. Kastrati, K. Tiroch, S. Schulz, J. Pache, S. Pinieck, S. Massberg, M. Seyfarth, K.L. Laugwitz, K.A. Birkmeier, A. Schmig, J. Mehilli ISAR-TEST-2 2-Year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents J Am Coll Cardiol 55 2010 2536 2543
16. S.G. Ellis, J.J. Popma, J.M. Lasala, J.J. Koglin, D.A. Cox, J. Hermiller, C. O'Shaughnessy, J.T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, and G.W. Stone Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial J Am Coll Cardiol 45 2005 1193 1200 (Pubitemid 40523136)
17. L. Mauri, E.J. Orav, and R.E. Kuntz Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison Circulation 111 2005 3435 3442 (Pubitemid 40923397)